Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1181675

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1181675

Specialty Enzymes Market - Global Outlook & Forecast 2022-2027

PUBLISHED:
PAGES: 221 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4200
PDF (5 User License)
USD 4999
PDF (Corporate User License)
USD 5999

Add to Cart

The global specialty enzymes market is expected to grow at a CAGR of 7.46% during 2022-2027.

MARKET OVERVIEW

  • Factors such as the rapidly increasing global population, increasing research & development, spreading new infectious diseases, increasing biofuel usage, and growing agriculture industry led to increased demand for specialty enzymes in the global market. The major drivers of the specialty enzymes market include the increasing health consciousness and intense penetration of the pharmaceutical, diagnostics, and biotechnology industries.
  • Specialty enzymes are used in various industries for various purposes. In the pharmaceutical industry, these are used for manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments. The demand is increasing due to increasing awareness and changing government policies. With the growing specialty enzymes markets, companies must increase the supply of raw materials to produce enzymes in bulk quantities. In the pharmaceutical industry, companies have started using biobased drugs to improve product quality. Companies are adopting sustainable standards in their manufacturing processes. The specialty enzymes market has helped to reduce the by-products in the production process. Companies are getting good financial returns by using specialty enzymes in the production processes. Thus, the global demand for specialty enzymes is increasing.
  • The US contributed more than half of the overall demand in North America. Globally, the demand for specialty enzymes is very high in the US, and North America dominates the global specialty enzymes market. The US has the world's top 10 pharmaceutical companies' head offices. Thus, the demand for specialty enzymes in North America's pharmaceutical industry is increasing with the growing pharmaceutical industry.

MARKET TRENDS & DRIVERS

Increased Use in Diagnostics Sector

  • The diagnostics industry includes two categories such as pathology and radiology. Pathology is used for testing all types of illness, whereas radiology is used for testing images related to diagnoses such as x-rays, CT scans, and others. For the research & development of vaccines for various infectious diseases, enzymes are used. Enzymes are used in testing infectious diseases such as coronaviruses and influenza and are also used in nucleic acid detection. The enzymes are used in the diagnostics and analysis of biological abnormalities.
  • The diagnostics segment plays a crucial role in the healthcare sector. After the Covid-19 pandemic, the demand for proper diagnostic equipment and processes in the diagnostics sector is growing rapidly. In the testing of coronaviruses and other infectious diseases, enzymes are used. For immediate recovery from coronavirus diseases, antibiotics are used, which are produced from enzymes. Thus, the specialty enzymes market in the diagnostic sector is increasing globally.

Increasing Demand from Pharmaceutical Industry

  • The global revenue of the pharmaceutical industry is increasing due to the global demand for pharmaceutical products. The factors driving the demand for pharmaceutical products include changing clinical practices, aging-related issues, and rising chronic diseases. After the Covid-19 pandemic, the demand for pharmaceutical products used to improve quality of life and preventive approach. The global market of pharmaceutical drugs is increasing due to the lowering the regulatory barrier for new drugs in the US.
  • The health consciousness of people has increased after the Covid-19 pandemic. People prefer bio-based pharmaceutical products. Thus, the demand for bio-based substances used in manufacturing antibiotics is rising. Specialty enzymes are used in the pharmaceutical industry to increase the reaction rate and produce the desired molecules, contributing to the specialty enzymes market growth.

INDUSTRY RESTRAINTS

Technical Barriers Affecting Specialty Enzymes Market

  • Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, specialty enzymes play an essential role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of specialty enzymes. The process is time-consuming and requires more catalysts to fulfilling the need of the chemical reaction process. For the manufacturing process of these enzymes, specific conditions such as new concentration, new substrate, and other conditions are required which are not found readily in nature. These unresolved challenges make specialty enzymes unpredictive. Thus, more research & development is necessary for making enzymes in bulk amounts, creating a barrier to the specialty enzymes market growth.

SEGMENTATION INSIGHTS

INSIGHTS BY END-USE

In the pharmaceutical industry, specialty enzymes are very useful and good for treating various diseases. As there is increasing demand for pharmaceutical products, the enzyme has become essential to meet the demand for sustainable and safe industry processes. The specialty enzymes are primarily used in the pharmaceutical and biotechnology industry for research & development and diagnostics. The global specialty enzymes market in the pharmaceutical industry was valued at USD 976.56 million in 2021. The demand for specialty enzymes in North America and APAC is very high due to the increasing pharmaceutical and biotechnology industry.

In the biotechnology industry, specialty enzymes are used to increase biochemical reaction rates. Lipases are used in dietary drugs and it is used to increase the metabolism rate. Polymerases & nucleases are used in DNA amplification. In DNA amplification, the increase in the number of the gene causes an increase in proteins and RNA. Thus, it may increase the cancer cells or lower the anticancer cells. Hence, the polymerases & nucleases-based enzymes demand is growing in the global specialty enzymes market.

Segmentation by End Use

  • Pharmaceutical
  • Biotechnology
  • Diagnostics
  • Other Specialty

INSIGHTS BY TYPE

Carbohydrases have dominated the global specialty enzymes market and is expected to reach USD 1.9 billion by 2027. Carbohydrases are mainly used in the pharmaceutical industry as specialty enzymes. Most of these enzymes used in the pharmaceutical industry are produced from microorganisms, animals, and plants. Carbohydrases are further classified into glucosidase, pectinases, alpha, beta amylases, cellulases, mannanases, galacto, and pullulanase. These are the cost-effective processes in industrial applications; thus, a cheap technique is required to obstruct.

The global proteases-based specialty enzymes market surpassed USD813 million in 2021. The proteases are used in the biotechnology, pharmaceutical, and diagnostics industries-the high use of proteases in the pharmaceutical industry for prognostic and diagnostic biomarkers. Based on the catalysis mechanism, the proteases are classified into additional classes, such as glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.

Segmentation by Type

  • Carbohydrase
  • Proteases
  • Lipases
  • Polymerases & nucleases

INSIGHTS BY SOURCE

Globally, microorganisms-based enzymes contributed 77.47%, followed by animal and plant-based enzymes in 2021 in the global specialty enzymes market. The demand for specialty enzymes is very high in North America, followed by Europe and APAC. Microorganisms and plant-based enzymes are easily found in the environment. Animal-based enzymes have fewer resources, and it isn't easy to produce in bulk quantities. Thus, companies are focusing on producing enzymes from microorganisms and plants.

The global plants-based specialty enzymes market was valued at USD 297.07 million in 2021. These are used in the agriculture industry to reduce insects from crops. The few plant-based enzymes are phosphatase, esterase, glucanase, chitinase, and others. These enzymes play a crucial role in the production of nutrition. Further, plant-based enzymes are being used to manufacture drugs in the pharmaceutical industry to improve the digestive system.

Segmentation by Source

  • Microorganisms
  • Plants
  • Animal

GEOGRAPHICAL ANALYSIS

The global specialty enzymes market is diverse, with many established and potential growth markets. North America is the leading market because of rapidly developing infrastructure and readily increasing population, increasing demand for various pharmaceutical, biotechnology, and diagnostics industries. The specialty enzymes market in North America was valued at USD 1.2 billion in 2021.

Europe is the second-largest market for specialty enzymes. The growth is supported by the increasing demand for healthy pharmaceutical products, which is attributed to the rising health consciousness. Germany, France, Italy, Spain, the UK, Russia, and others led the region. In European countries, various companies are producing specialty enzymes that contribute to the global specialty enzymes market, such as BASF SE (Germany), Johnson Matthey (UK), Biocatalysts (UK), BBI Solutions (UK), and others. Furthermore, the demand is expected to grow significantly as the APAC region population has grown tremendously in recent years. China, Japan, India, and South Korea led the region. The population of APAC countries is increasing rapidly; thus, demand for pharmaceutical and diagnostics specialty enzymes is increasing. China, India, and Japan are the major pharmaceutical industry players in the APAC region.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

COMPETITIVE LANDSCAPE

The major companies in the specialty enzymes market are following the merger and acquisition strategy. This gives companies a competitive advantage that boosts their market share of the company. The key companies have undertaken various strategies to grow in the market. The growth in sustainable processes and initiatives has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable specialty enzyme products.

Some major players in the global specialty enzymes market include Roche (Switzerland), BASF SE (Germany), DuPont (US), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies like acquisitions, expansion, joint ventures, new product development, and others to increase their revenues in the industry. Other prominent companies such as Chr. Hansen Holding A/S (Denmark), Codexis (US), BBI Solutions (UK), and others have invested significant capital in R&D to develop specialty enzymes-based products that will appeal to customers. Therefore, these other prominent companies are giving tough competition to major companies.

Key Vendors

  • BASF SE
  • DSM
  • DuPont
  • F. Hoffmann-La Roche Ltd
  • Novozymes

Other Prominent Vendors

  • Amano Enzyme Inc.
  • Amayra Biotech AG
  • Antozyme Biotech Pvt Ltd
  • Aumgene Biosciences
  • Aumenzymes
  • BBI Solutions
  • Biocatalysts
  • Codexis
  • Hansen Holding A/S
  • Dyadic International Inc.
  • Iosynth
  • Merck KGaA
  • Nature Bioscience Pvt. Ltd.
  • Specialty Enzymes & Probiotics
  • Zymtronix Inc.

KEY QUESTIONS ANSWERED

  • 1. What was the global specialty enzymes market size in 2021?
  • 2. What is the growth rate of the global specialty enzymes market?
  • 3. What are the key trends in the Specialty Enzymes Market in the world?
  • 4. Which are the key companies in the global specialty enzymes market?
  • 5. Which end-use segment is estimated to lead the Global Specialty Enzymes Market?
Product Code: ARZ221111

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 MARKET SYNOPSIS
    • 6.2.1 DRIVERS
    • 6.2.2 OPPORTUNITY
    • 6.2.3 CHALLENGES
  • 6.3 SEGMENT REVIEW
    • 6.3.1 END-USE
    • 6.3.2 TYPE
    • 6.3.3 SOURCE
    • 6.3.4 GEOGRAPHY
  • 6.4 COMPANIES & STRATEGIES

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW
  • 8.2 VALUE CHAIN ANALYSIS
    • 8.2.1 RAW MATERIALS
    • 8.2.2 SPECIALTY ENZYME MANUFACTURERS
    • 8.2.3 DISTRIBUTORS
    • 8.2.4 APPLICATIONS
  • 8.3 MACROECONOMIC FACTORS
    • 8.3.1 PHARMACEUTICAL INDUSTRY

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 DEMAND FROM PHARMACEUTICAL INDUSTRY
  • 9.2 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PROFITABILITY & PRODUCTIVITY
  • 9.3 DEMAND FROM EMERGING ECONOMIES

10 MARKET GROWTH ENABLERS

  • 10.1 DEMAND FOR BIO-SOURCED PRODUCTS
  • 10.2 INCREASED USE IN DIAGNOSTICS SECTOR
  • 10.3 INCREASED R&D & PRODUCT INNOVATION IN DEVELOPED COUNTRIES

11 MARKET RESTRAINTS

  • 11.1 LACK OF AWARENESS OF BIO-BASED PRODUCTS
  • 11.2 EXISTENCE OF VARIOUS TECHNICAL BARRIERS
  • 11.3 HIGH MANUFACTURING COST

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 BY TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 CARBOHYDRASES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 PROTEASES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 LIPASES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 POLYMERASES & NUCLEASES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 OTHER
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY

14 BY END-USE

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 PHARMACEUTICAL
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 BIOTECHNOLOGY
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 DIAGNOSTICS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 OTHER END-USE
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY

15 BY SOURCE

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 MICROORGANISM
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 PLANT
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 ANIMAL
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
    • 15.5.3 MARKET BY GEOGRAPHY

16 GEOGRAPHY

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 TYPE
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 END-USE
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 SOURCE
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 KEY COUNTRIES
  • 17.7 US
    • 17.7.1 MARKET SIZE & FORECAST
  • 17.8 CANADA
    • 17.8.1 MARKET SIZE & FORECAST

18 EUROPE

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 TYPE
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 END-USE
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 SOURCE
    • 18.5.1 MARKET SIZE & FORECAST
  • 18.6 KEY COUNTRIES
  • 18.7 GERMANY
    • 18.7.1 MARKET SIZE & FORECAST
  • 18.8 FRANCE
    • 18.8.1 MARKET SIZE & FORECAST
  • 18.9 ITALY
    • 18.9.1 MARKET SIZE & FORECAST
  • 18.10 SPAIN
    • 18.10.1 MARKET SIZE & FORECAST
  • 18.11 UK
    • 18.11.1 MARKET SIZE & FORECAST
  • 18.12 RUSSIA
    • 18.12.1 MARKET SIZE & FORECAST
  • 18.13 REST OF EUROPE
    • 18.13.1 MARKET SIZE & FORECAST

19 APAC

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 TYPE
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 END-USE
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 SOURCE
    • 19.5.1 MARKET SIZE & FORECAST
  • 19.6 KEY COUNTRIES
  • 19.7 CHINA
    • 19.7.1 MARKET SIZE & FORECAST
  • 19.8 JAPAN
    • 19.8.1 MARKET SIZE & FORECAST
  • 19.9 INDIA
    • 19.9.1 MARKET SIZE & FORECAST
  • 19.10 SOUTH KOREA
    • 19.10.1 MARKET SIZE & FORECAST
  • 19.11 REST OF APAC
    • 19.11.1 MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 TYPE
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 END-USE
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 SOURCE
    • 20.5.1 MARKET SIZE & FORECAST
  • 20.6 KEY COUNTRIES
  • 20.7 SAUDI ARABIA
    • 20.7.1 MARKET SIZE & FORECAST
  • 20.8 SOUTH AFRICA
    • 20.8.1 MARKET SIZE & FORECAST
  • 20.9 REST OF MIDDLE EAST & AFRICA
    • 20.9.1 MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 TYPE
    • 21.3.1 MARKET SIZE & FORECAST
  • 21.4 END-USE
    • 21.4.1 MARKET SIZE & FORECAST
  • 21.5 SOURCE
    • 21.5.1 MARKET SIZE & FORECAST
  • 21.6 KEY COUNTRIES
  • 21.7 BRAZIL
    • 21.7.1 MARKET SIZE & FORECAST
  • 21.8 MEXICO
    • 21.8.1 MARKET SIZE & FORECAST
  • 21.9 REST OF LATIN AMERICA
    • 21.9.1 MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

  • 22.1 COMPETITION OVERVIEW
  • 22.2 RECENT DEVELOPMENTS

23 KEY COMPANY PROFILES

  • 23.1 BASF SE
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 FINANCIAL OVERVIEW
    • 23.1.3 PRODUCT OFFERINGS
    • 23.1.4 KEY STRATEGIES
    • 23.1.5 KEY STRENGTHS
    • 23.1.6 KEY OPPORTUNITIES
  • 23.2 DSM
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 FINANCIAL OVERVIEW
    • 23.2.3 PRODUCT OFFERINGS
    • 23.2.4 KEY STRATEGIES
    • 23.2.5 KEY STRENGTHS
    • 23.2.6 KEY OPPORTUNITIES
  • 23.3 DUPONT
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 FINANCIAL OVERVIEW
    • 23.3.3 PRODUCT OFFERINGS
    • 23.3.4 KEY STRATEGIES
    • 23.3.5 KEY STRENGTHS
    • 23.3.6 KEY OPPORTUNITIES
  • 23.4 F. HOFFMANN-LA ROCHE LTD
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 FINANCIAL OVERVIEW
    • 23.4.3 PRODUCT OFFERINGS
    • 23.4.4 KEY STRATEGIES
    • 23.4.5 KEY STRENGTHS
    • 23.4.6 KEY OPPORTUNITIES
  • 23.5 NOVOZYMES
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 FINANCIAL OVERVIEW
    • 23.5.3 PRODUCT OFFERINGS
    • 23.5.4 KEY STRATEGIES
    • 23.5.5 KEY STRENGTHS
    • 23.5.6 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 AMANO ENZYME INC.
    • 24.1.1 COMPANY OVERVIEW
    • 24.1.2 BUSINESS OVERVIEW
    • 24.1.3 PRODUCT OFFERINGS
  • 24.2 AMYRA BIOTECH AG
    • 24.2.1 COMPANY OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 ANTOZYME BIOTECH PVT LTD
    • 24.3.1 COMPANY OVERVIEW
    • 24.3.2 BUSINESS OVERVIEW
    • 24.3.3 PRODUCT OFFERINGS
  • 24.4 AUMGENE BIOSCIENCES
    • 24.4.1 COMPANY OVERVIEW
    • 24.4.2 BUSINESS OVERVIEW
    • 24.4.3 PRODUCT OFFERINGS
  • 24.5 AUMENZYMES
    • 24.5.1 COMPANY OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 BBI SOLUTIONS
    • 24.6.1 COMPANY OVERVIEW
    • 24.6.2 BUSINESS OVERVIEW
    • 24.6.3 PRODUCT OFFERINGS
  • 24.7 BIOCATALYSTS
    • 24.7.1 COMPANY OVERVIEW
    • 24.7.2 BUSINESS OVERVIEW
    • 24.7.3 PRODUCT OFFERINGS
  • 24.8 CODEXIS
    • 24.8.1 COMPANY OVERVIEW
    • 24.8.2 BUSINESS OVERVIEW
    • 24.8.3 PRODUCT OFFERINGS
  • 24.9 CHR. HANSEN HOLDING A/S
    • 24.9.1 COMPANY OVERVIEW
    • 24.9.2 BUSINESS OVERVIEW
    • 24.9.3 PRODUCT OFFERINGS
  • 24.10 DYADIC INTERNATIONAL INC.
    • 24.10.1 COMPANY OVERVIEW
    • 24.10.2 BUSINESS OVERVIEW
    • 24.10.3 PRODUCT OFFERINGS
  • 24.11 IOSYNTH
    • 24.11.1 COMPANY OVERVIEW
    • 24.11.2 BUSINESS OVERVIEW
    • 24.11.3 PRODUCT OFFERINGS
  • 24.12 MERCK KGAA
    • 24.12.1 COMPANY OVERVIEW
    • 24.12.2 BUSINESS OVERVIEW
    • 24.12.3 PRODUCT OFFERINGS
  • 24.13 NATURE BIOSCIENCE PVT. LTD.
    • 24.13.1 COMPANY OVERVIEW
    • 24.13.2 BUSINESS OVERVIEW
    • 24.13.3 PRODUCT OFFERINGS
  • 24.14 SPECIALTY ENZYMES & PROBIOTICS
    • 24.14.1 COMPANY OVERVIEW
    • 24.14.2 BUSINESS OVERVIEW
    • 24.14.3 PRODUCT OFFERINGS
  • 24.15 ZYMTRONIX, INC.
    • 24.15.1 COMPANY OVERVIEW
    • 24.15.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 TYPE
    • 26.1.1 CARBOHYDRASES
    • 26.1.2 PROTEASES
    • 26.1.3 LIPASES
    • 26.1.4 POLYMERASES & NUCLEASES
    • 26.1.5 OTHER
  • 26.2 END-USE
    • 26.2.1 PHARMACEUTICAL
    • 26.2.2 BIOTECHNOLOGY
    • 26.2.3 DIAGNOSTICS
    • 26.2.4 OTHER END-USE
  • 26.3 SOURCE
    • 26.3.1 MICROORGANISM
    • 26.3.2 PLANT
    • 26.3.3 ANIMAL
  • 26.4 GEOGRAPHY
  • 26.5 NORTH AMERICA
    • 26.5.1 TYPE
    • 26.5.2 END-USE
    • 26.5.3 SOURCE
  • 26.6 EUROPE
    • 26.6.1 TYPE
    • 26.6.2 END-USE
    • 26.6.3 SOURCE
  • 26.7 APAC
    • 26.7.1 TYPE
    • 26.7.2 END-USE
    • 26.7.3 SOURCE
  • 26.8 MIDDLE EAST & AFRICA
    • 26.8.1 TYPE
    • 26.8.2 END-USE
    • 26.8.3 SOURCE
  • 26.9 LATIN AMERICA
    • 26.9.1 TYPE
    • 26.9.2 END-USE
    • 26.9.3 SOURCE

27 APPENDIX

  • 27.1 ABBREVIATIONS
Product Code: ARZ221111

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL SPECIALTY ENZYMES MARKET
  • EXHIBIT 2 GLOBAL SPECIALTY ENZYMES MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 GLOBAL SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 4 SHARE OF GLOBAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY IN 2021 (%)
  • EXHIBIT 5 VALUE CHAIN ANALYSIS OF GLOBAL SPECIALTY ENZYMES MARKET
  • EXHIBIT 6 GEOGRAPHICAL ANALYSIS - SALES OF NEW MEDICINES LAUNCHED (2015-2020)
  • EXHIBIT 7 PHARMACEUTICAL R&D EXPENDITURE: EUROPE & US ($ MILLION) (1990-2020)
  • EXHIBIT 8 IMPACT OF DEMAND FROM PHARMACEUTICAL INDUSTRY
  • EXHIBIT 9 GLOBAL NUMBER OF PHARMACEUTICAL DRUG USERS (MILLION)
  • EXHIBIT 10 IMPACT OF ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PROFITABILITY & PRODUCTIVITY
  • EXHIBIT 11 IMPACT OF DEMAND FROM EMERGING ECONOMIES
  • EXHIBIT 12 APAC PHARMACEUTICAL MARKET SIZE 2018 ($ BILLION)
  • EXHIBIT 13 IMPACT OF DEMAND FOR BIO-SOURCED PRODUCTS
  • EXHIBIT 14 IMPACT OF INCREASED USE IN DIAGNOSTICS SECTOR
  • EXHIBIT 15 % MORTALITY DUE TO CARDIOVASCULAR DISEASES, CANCER & DIABETES IN SELECT COUNTRIES (AGES BETWEEN 30 AND 70)
  • EXHIBIT 16 IMPACT OF INCREASED R&D & PRODUCT INNOVATION IN DEVELOPED COUNTRIES
  • EXHIBIT 17 IMPACT OF LACK OF AWARENESS OF BIO-BASED PRODUCTS
  • EXHIBIT 18 IMPACT OF EXISTENCE OF VARIOUS TECHNICAL BARRIERS
  • EXHIBIT 19 CONDITIONS REQUIRED FOR ENZYMOLOGY PROCESS
  • EXHIBIT 20 IMPACT OF HIGH MANUFACTURING COST
  • EXHIBIT 21 DESIGNED SPECIALTY ENZYME PRODUCTION FACILITY ANNUAL OPERATING COST (%)
  • EXHIBIT 22 GLOBAL SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 23 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 24 INCREMENTAL GROWTH BY TYPE 2021 & 2027
  • EXHIBIT 25 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 26 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 27 GLOBAL LIPASES SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 28 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 29 GLOBAL OTHER SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 30 INCREMENTAL GROWTH BY END-USE 2021 & 2027
  • EXHIBIT 31 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 32 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 33 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 34 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 35 INCREMENTAL GROWTH BY SOURCE 2021 & 2027
  • EXHIBIT 36 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 37 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 38 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 40 NORTH AMERICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 41 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 42 US SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 43 CANADA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 44 EUROPE SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 45 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 46 GERMANY SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 47 FRANCE SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 48 ITALY SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 49 SPAIN SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 50 UK SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 51 RUSSIA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 52 REST OF EUROPE SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 53 APAC SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 54 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 55 CHINA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 56 JAPAN SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 57 INDIA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 58 SOUTH KOREA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 59 REST OF APAC SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 60 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 61 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 62 SAUDI ARABIA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 63 SOUTH AFRICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 64 REST OF MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 65 LATIN AMERICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH IN REST OF LATIN AMERICA 2021 & 2027
  • EXHIBIT 67 BRAZIL SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 68 MEXICO SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 69 REST OF LATIN AMERICA SPECIALTY ENZYMES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 70 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 71 SEGMENTAL REVENUE: 2021 ($ BILLION)
  • EXHIBIT 72 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 73 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 74 SEGMENTAL REVENUE: 2021 ($ BILLION)
  • EXHIBIT 75 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 76 SEGMENTAL REVENUE: 2021 ($ BILLION)
  • EXHIBIT 77 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 78 AMANO ENZYME INC.: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 79 ANTOZYME BIOTECH PVT LTD: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 80 AUMGENE BIOSCIENCES: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 81 BBI SOLUTIONS: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 82 BIOCATALYSTS: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 83 CODEXIS: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 84 CHR. HANSEN HOLDING A/S: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 85 DYADIC INTERNATIONAL INC.: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 86 IOSYNTH: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 87 MERCK KGAA: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 88 NATURE BIOSCIENCE PVT. LTD.: BUSINESS & FINANCIAL OVERVIEW
  • EXHIBIT 89 SPECIALTY ENZYMES & PROBIOTICS: BUSINESS & FINANCIAL OVERVIEW

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 OVERVIEW OF PHARMACEUTICAL INDUSTRY IN EUROPE ($ MILLION)
  • TABLE 4 DEVELOPMENT OF GLOBAL MEDICINES (UNITS)
  • TABLE 5 CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 6 CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 7 PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 8 PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 9 LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 10 LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 11 POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 12 POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 13 OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 14 OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 15 PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 16 PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 17 BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 18 BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 19 DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 20 DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 21 OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 22 OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 23 MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 24 MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 25 PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 26 PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 27 ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 28 ANIMALS-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 29 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 30 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 (%)
  • TABLE 31 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 32 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 (%)
  • TABLE 33 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 34 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 (%)
  • TABLE 35 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 36 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 (%)
  • TABLE 37 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 38 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 (%)
  • TABLE 39 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 40 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 (%)
  • TABLE 41 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 42 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 (%)
  • TABLE 43 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 44 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 (%)
  • TABLE 45 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 46 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 (%)
  • TABLE 47 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 48 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 (%)
  • TABLE 49 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 (%)
  • TABLE 51 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 52 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 (%)
  • TABLE 53 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 54 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 (%)
  • TABLE 55 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 56 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 (%)
  • TABLE 57 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 58 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 (%)
  • TABLE 59 BASF SE: MAJOR PRODUCT OFFERINGS
  • TABLE 60 DSM: MAJOR PRODUCT OFFERINGS
  • TABLE 61 DUPONT: MAJOR PRODUCT OFFERINGS
  • TABLE 62 F. HOFFMANN-LA ROCHE LTD: MAJOR PRODUCT OFFERINGS
  • TABLE 63 NOVOZYMES: MAJOR PRODUCT OFFERINGS
  • TABLE 64 AMANO ENZYME INC.: MAJOR PRODUCT OFFERINGS
  • TABLE 65 AMAYRA BIOTECH AG: MAJOR PRODUCT OFFERINGS
  • TABLE 66 ANTOZYME BIOTECH PVT LTD: MAJOR PRODUCT OFFERINGS
  • TABLE 67 AUMGENE BIOSCIENCES: MAJOR PRODUCT OFFERINGS
  • TABLE 68 AUMENZYMES: MAJOR PRODUCT OFFERINGS
  • TABLE 69 BBI SOLUTIONS: MAJOR PRODUCT OFFERINGS
  • TABLE 70 BIOCATALYSTS: MAJOR PRODUCT OFFERINGS
  • TABLE 71 CODEXIS: MAJOR PRODUCT OFFERINGS
  • TABLE 72 C CHR. HANSEN HOLDING A/S: MAJOR PRODUCT OFFERINGS
  • TABLE 73 DYADIC INTERNATIONAL INC.: MAJOR PRODUCT OFFERINGS
  • TABLE 74 IOSYNTH: MAJOR PRODUCT OFFERINGS
  • TABLE 75 MERCK KGAA: MAJOR PRODUCT OFFERINGS
  • TABLE 76 NATURE BIOSCIENCE PVT. LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 77 SPECIALTY ENZYMES & PROBIOTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 78 ZYMTRONIX, INC.: MAJOR PRODUCT OFFERINGS
  • TABLE 79 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 80 GLOBAL CARBOHYDRASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 81 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 82 GLOBAL PROTEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 83 GLOBAL LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 84 GLOBAL LIPASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 85 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 86 GLOBAL POLYMERASES & NUCLEASES SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 87 GLOBAL OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 88 GLOBAL OTHER SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 89 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 90 GLOBAL PHARMACEUTICAL SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 91 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 92 GLOBAL BIOTECHNOLOGY SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 93 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 94 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 95 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 96 GLOBAL OTHER END-USE SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 97 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 98 GLOBAL MICROORGANISM-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 99 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 100 GLOBAL PLANT-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 101 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 102 GLOBAL ANIMAL-BASED SPECIALTY ENZYMES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 103 NORTH AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 104 NORTH AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 105 NORTH AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 106 EUROPE SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 107 EUROPE SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 108 EUROPE SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 109 APAC SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 110 APAC SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 111 APAC SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
  • TABLE 115 LATIN AMERICA SPECIALTY ENZYMES MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 116 LATIN AMERICA SPECIALTY ENZYMES MARKET BY END-USE 2021-2027 ($ MILLION)
  • TABLE 117 LATIN AMERICA SPECIALTY ENZYMES MARKET BY SOURCE 2021-2027 ($ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!